|
|
||||||||
1From the Tokyo New Drug Research Laboratories, Kowa Company Ltd., Tokyo, Japan; and the 2Department of Biomolecular Recognition and Ophthalmology, Yamaguchi University School of Medicine, Yamaguchi, Japan.
PURPOSE. To investigate the possible role of urokinase-type plasminogen activator (uPA) in corneal epithelial wound healing by examining its expression both in the rabbit corneal epithelium in situ and in rabbit corneal epithelial (RCE) cells in vitro.
METHODS. The rabbit cornea was subjected to mechanical wounding, and frozen sections of the tissue were subsequently prepared and subjected both to immunostaining with antibodies to uPA and to in situ zymography for the detection of PA activity. RCE cell monolayers were also subjected to scrape wounding, after which they were immunostained for uPA. The amounts of uPA protein in the culture medium and of uPA mRNA in cell lysates were also determined by enzyme-linked immunosorbent assay and by reverse transcription and real-time quantitative polymerase chain reaction analysis, respectively.
RESULTS. Immunostaining and in situ zymography of the wounded cornea revealed that uPA was restricted to the leading edge of the migrating corneal epithelium. In contrast, tissue-type PA was expressed throughout the corneal epithelium. Scraping of RCE cell monolayers induced the expression of uPA in the migrating cells at the wound edge. The amount of uPA in the culture medium of RCE cells increased with the number of scrape wounds applied. Wounding also induced a time-dependent increase in the abundance of uPA mRNA in the cell monolayers. The migration of RCE cells was inhibited by antibodies to uPA.
CONCLUSIONS. Mechanical wounding induces up-regulation of uPA at both the protein and mRNA levels in corneal epithelial cells. uPA may thus contribute to epithelial cell migration during corneal epithelial wound healing.
This article has been cited by other articles:
![]() |
M. Watanabe, S. Kondo, K. Mizuno, W. Yano, H. Nakao, Y. Hattori, K. Kimura, and T. Nishida Promotion of Corneal Epithelial Wound Healing In Vitro and In Vivo by Annexin A5 Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 1862 - 1868. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, T. Minamino, O. Tsukamoto, T. Yujiri, Y. Shintani, K.-i. Okada, Y. Nagamachi, M. Fujita, A. Hirata, S. Sanada, et al. Ablation of MEK Kinase 1 Suppresses Intimal Hyperplasia by Impairing Smooth Muscle Cell Migration and Urokinase Plasminogen Activator Expression in a Mouse Blood-Flow Cessation Model Circulation, April 5, 2005; 111(13): 1672 - 1678. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Leonardi, P. Brun, M. T. Sartori, R. Cortivo, C. DeDominicis, G. Saggiorato, G. Abatangelo, and A. G. Secchi Urokinase Plasminogen Activator, uPa Receptor, and Its Inhibitor in Vernal Keratoconjunctivitis Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1364 - 1370. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Bernstein, R. S. Greenberg, L. Taliana, and S. K. Masur Urokinase Anchors uPAR to the Actin Cytoskeleton Invest. Ophthalmol. Vis. Sci., September 1, 2004; 45(9): 2967 - 2977. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |